By Christina Sue Cherel

Junior Faculty Win Career Development Professorships

March 24th, 2014 in Faculty Spotlight

Hui-e1344014884721

Hui Feng spends a lot of time staring through zebra fish. Through because these vertebrates, which have a great deal of genetics in common with humans, are transparent. In fact, one particular breed, called Casper—after the Friendly Ghost—is so phantasmal that Feng says that “you can read newspapers through this fish.”

Feng doesn’t read the news through them, though. The School of Medicine assistant professor of pharmacology and medicine is more interested in tracking the pathways of dyed tumor cells as they metastasize through the zebra fish’s vasculature, which is tinted a contrasting color. In the less than two years since her tank-filled lab opened, she has identified genes that, when blocked with targeted treatments, could prevent the metastasis of certain types of cancer, like the most stubborn forms of leukemia.

In recognition of her groundbreaking work, Feng was awarded the Ralph Edwards Career Development Professorship, which recognizes MED researchers. The award was made possible this year by the estate of obstetrician and gynecologist Ralph Edwards (MED’52).

Feng, director of the Laboratory of Zebrafish Genetics & Cancer Therapeutics, says the honor reminds her that University officials appreciate faculty research and they want to support it. “It’s not just about the money,” she says. “The spiritual or mental support really means so much to us.”

Karen Antman, MED dean and Medical Campus provost, recalls the researcher’s discoveries early in her career, which found their way to top-tier research journals, including NatureCell BiologyCancer Cell, the Journal of Experimental Medicine, and PNAS. A graduate of Beijing Medical University, Feng completed a master’s in cardiovascular pharmacology at Peking Union Medical College and a doctorate in cellular biology at the University of Georgia.

“Since joining the School of Medicine faculty,” Antman says, “Dr. Feng has demonstrated an exceptional level of scholarship, mentorship, teaching, and collegiality and quickly established herself as an independent research scientist, effectively and efficiently setting up a robust research program.”

Feng is one of three assistant professors who were given career development awards, which recognize junior faculty who have been at the University for less than two years and have held no prior professorships. Cornel Ban, a College of Arts & Sciences assistant professor of international relations, received the inaugural Stuart and Elizabeth Pratt Career Development Professorship, dedicated to CAS scholars. And Nachiketa Sahoo, a School of Management assistant professor of information systems, was awarded the Reidy Family Career Development Professorship, which has recognized faculty members in SMG and the College of Engineering in alternating years since 2010.

Contributions from BU trustee Stuart W. Pratt (CAS’69) and his wife, Elizabeth, and trustee Richard D. Reidy (SMG’82) and his wife, Minda G. Reidy (SMG’82, GSM’84) made the professorships possible.

Each award comes with a three-year nonrenewable stipend used to support scholarly or creative work and to cover a portion of the faculty member’s salary. Deans of the respective schools or colleges nominate faculty for these honors, and the Office of the Provost makes the final selections.

“We are extremely grateful to Stuart and Elizabeth Pratt, Richard and Minda Reidy, and posthumously, Ralph Edwards for their generosity and for the vision they’ve shown in supporting the future of these very important fields,” says Jean Morrison, University provost and chief academic officer. These three professors were recognized for “their extraordinary accomplishments in areas of study, passion for the creation and transmission of knowledge, and their efforts to enhance the student experience.”

Ban’s research has focused on economic issues in Brazil, Spain, and Romania, and spans three principal topics: international finance, international economic organizations, and the diffusion of international economic ideas. He describes his first book, Governing Crises: The International Politics of Crisis Economics from Bretton Woods to the Great Recession, not yet published, as “a cautionary tale about how much we don’t know about how the financial markets work.” He is an expert on the failure of economic models used by governments or international banks to predict the financial crisis that swept the world within the past decade.

Ban earned a bachelor’s from Babes-Bolyai University, in Romania, a master’s degree from the University of Delaware, and a doctorate in political science from the University of Maryland. He says the award will give him the time and funding to launch his next book project, which will focus on the dynamics of international finance over the past couple of decades. “Without this kind of support,” he says, “I could not get it done.”

Andrew Bacevich, a CAS professor of history and international relations and acting chair of international relations, calls Ban an “emerging superstar” in the department. “Since his arrival a year ago, he has become a valued asset,” he says. “His performance as a teacher and scholar has demonstrated that he is precisely the sort of young faculty member for whom the Stuart and Elizabeth Pratt Career Development Professorship is designed.”

Sahoo holds a master’s degree in knowledge discovery and data mining and a doctorate in information systems and management, both from Carnegie Mellon University. His current research focus is on improving personalized information filtering techniques, such as that used by Netflix and Amazon, to help customers find products that best match their past interests. Recognizing that people are dynamic and that their preferences change over time, he has adjusted these filtering techniques so that they show more accurate recommendations across a variety of platforms.

In a separate branch of research, Sahoo is analyzing the messages exchanged between individuals on corporate social media, such as blogs, to identify expertise that exists inside a company.

“New technologies to help people connect to each other are exacerbating the problem of information overload at a personal level,” says Sahoo. “There is too much information to sift through and there is limited time. It’s important to develop tools and techniques that help us find the bits of relevant information faster.”

Sahoo says he will use the award to hire a research assistant to help with data collection and analysis.

“Dr. Sahoo is a wonderful addition to our faculty: a productive researcher, a great colleague, and a committed teacher,” says Kenneth Freeman, SMG’s Allen Questrom Professor and Dean.

Original article was authored by Leslie Friday and posted on BU Today 13 September 2013.

Rebecca Burke awarded the Joseph Cochin Award in Pharmacology and Medical Ethics

March 21st, 2014 in Recent News

Burke 2011-9-21 ImageAt the Student Award Ceremony on Match Day, March 21, 2014, Rebecca Burke was awarded the Joseph Cochin Award in Pharmacology and Medical Ethics. This award honors the memory of Joseph Cochin, MD, PhD, who served as Professor of Pharmacology and Experimental Therapeutics at BUSM for many years. Dr. Cochin was an internationally recognized expert on opioid analgesia, pain control and medical ethics. Becky, a student in the Biomolecular Pharmacology Training Program from 2008-2012, received this award in recognition of her high achievement in pharmacology and accomplishments in research under the mentorship of Jan K. Blusztajn, PhD. Becky will receive her MD and PhD degrees at the BUSM May Graduation Ceremony and will continue her professional training with a residency at the University of Virginia in Neurological Surgery. Congratulations to Becky!

Maya E. Woodbury awarded PhRMA Foundation Predoctoral Fellowship

December 19th, 2013 in Student Spotlight

maya_woodbury_portrait-150x150Maya Woodbury was recently awarded the Predoctoral Fellowship in Pharmacology/Toxicology through the PhRMA Foundation. The title of her approved proposal is “miR-155/STAT3 signaling: a novel pharmacological target for Down syndrome.” For this project, she will receive financial support for her research in the amount of $20,000 per year for two years. The Foundation only awards about 10 such grants nationally each year.

According to the PhRMA Foundation’s 2012 Annual Report, “the mission of the PhRMA Foundation is to support young scientists in disciplines important to the pharmaceutical industry by awarding them competitive research fellowships and grants at a critical point at the outset of their careers. The aim is to encourage young scientists who will be the leaders of tomorrow to pursue careers in research and education related to drug discovery.”

Maya is currently a student in the Graduate Program for Neuroscience and the Biomolecular Pharmacology Program through the Department of Pharmacology & Experimental Therapeutics at Boston University School of Medicine. She works in the Laboratory of Molecular NeuroTherapeutics under the mentorship of Dr. Tsuneya Ikezu.

Congratulations, Maya!

Dr. Valentina Sabino honored by The Peter F. McManus Charitable Trust Foundation

December 18th, 2013 in Recent News

10-3009-PHARMAHEAD-086The Peter F. McManus Charitable Trust Foundation recently honored Dr. Valentina Sabino for the second time with a grant to research the causes of alcohol addiction. The title of her approved project is “Neurobiological Bases of Alcohol Addiction.”

According to Dr. Sabino, “alcoholism constitutes one of the most serious public health problems worldwide. The World Health Organization estimates that about 2 billion people worldwide consume alcoholic beverages, of which 76.3 million have alcohol use disorders. Alcohol is estimated to cause 20%–30% of esophageal cancer, liver cancer and cirrhosis, homicide, seizures, and motor vehicle accidents, causing 3.2% of the total deaths.

This project will systematically explore the role of an understudied receptor system, the Sigma receptors, in genetic and chronic ethanol-induced animal models of alcoholism. The focus will be the Nucleus Accumbens, an important brain region for alcohol and drug addiction, proposed as being the specific region where Sigma receptors mediated neuroplasticity in addicted brains.

These experiments will provide insights into this novel receptor system as a key mechanism involved in excessive drinking and alcohol-seeking behavior and propose a novel therapeutic target for alcohol addiction.”

Dr. Sabino received her Ph.D. in Pharmacology in 2006. She is an Assistant Professor in the Department of Pharmacology & Experimental Therapeutics and Department of Psychiatry, and Co-Director of the Laboratory of Addictive Disorders at Boston University School of Medicine.

Congratulations, Dr. Sabino!

Dr. Camron Bryant selected as the recipient of the 2014 IBANGS Young Scientist Award

December 18th, 2013 in Recent News

2012-11-08 13.08.21Dr. Camron Bryant has been selected as the recipient of the 2014 IBANGS Young Scientist Award. The Young Scientist Award honors a scientist who is 7 or fewer years post first faculty or faculty-equivalent appointment, and whose area of research is in behavioural and neural genetics. Key considerations are the scientific importance of research discoveries, record of achievement and future scientific plans and projected impact on the field.

Dr. Bryant, Assistant Professor of Pharmacology and Psychiatry, is the Director of the Laboratory of Addiction Genetics.

Congratulations, Dr. Bryant!

Dr. Benjamin Wolozin Receives Alzheimer’s Association Zenith Fellows Award

December 4th, 2013 in Recent News

wolozin_2006From the Office of the Dean:

I am pleased to share that Benjamin Wolozin, MD, PhD, Professor, Pharmacology and Neurology, was awarded the Alzheimer’s Association Zenith Fellows Award.  Initiated in 1991, the award provides support for cutting edge basic science or biomedical research that addresses fundamental problems related to early detection, etiology pathogenesis, treatment and/or prevention of Alzheimer’s disease (AD). The award is valued at $450,000, which will be dispersed over three years.

The Wolozin Lab won the award with its proposal “It Takes TIA to Tangle: The Role of RNA Binding Proteins in AD.” The laboratory already has discovered a RNA binding protein that induces tau misfolding, one of the essential steps that leads to cognitive loss in AD. This award will allow the Wolozin Lab to experimentally induce the misfolding, investigate the factors that regulate the misfolding and in the future, potentially design therapeutics to prevent the misfolding.

Please join me in congratulating Dr. Wolozin on this award.

Karen Antman, MD
Provost, Boston University Medical Campus
Dean, School of Medicine
Professor of Medicine

BU Pharmacology Trainee Discovers FDA Approved Treatment for MS

November 14th, 2013 in Alumni Spotlight, Recent News

RhodesKenneth J. Rhodes, Ph.D., Vice President of Neurology Discovery at Biogen Idec and an alumni of the Boston University Pharmacology Training Program, led the team of researchers that developed Tecfidera, an oral medication that defends against relapsing Multiple Sclerosis (MS).

The Food and Drug Administration recently approved Tecfidera, also known as dimethyl fumarate, for treating relapsing multiple sclerosis. This new drug delays progression of physical disability and slows the development of brain lesions associated with MS. It also reduces the inflammation caused when the immune system attacks myelin, which ultimately results in less damage to myelin in the body. In a Biogen Idec press release, Dr. Kenneth Rhodes stated that, “these exciting results support further research, as the data suggest that neublastin may have the potential to promote sensory neuronal regeneration and functional recovery following injury. The neublastin program is part of Biogen Idec’s commitment to innovative neurological science and discovery.”

According to the Boston Business Journal, Tecfidera “tops the list of the biggest potential revenue-generating drugs launched so far this year in the U.S., with expected sales of $2.9 billion by 2018.”

Dr. Kenneth Rhodes joined Biogen Idec in May 2007 after spending ten years in the Neuroscience Department at Wyeth, where he also led neurodegeneration drug discovery teams researching MS among epilepsy, stroke, Parkinson’s and Alzheimer’s disease. He served as a postdoctoral trainee under the mentorship of Dr. David H. Farb, Professor and Chair of Pharmacology at Boston University School of Medicine, from 1992-1993. Dr. Rhodes has published over 50 research papers in peer-reviewed journals such as Nature, Neuron, and the Journal of Neuroscience and most recently was the Keynote Speaker for the 2013 BU-Pfizer Symposium on “Therapeutic Innovation: Oxidative Stress and the Next Generation of Discovery” held November 5, 2013.

2013 Pfizer Symposium – “Therapeutic Innovation: Oxidative Stress and the Next Generation of Discovery

November 14th, 2013 in Event Highlights

Please click here for the 2013 BU-Pfizer Symposium program book PDF file.

Therapeutic_Innovation_Symposium_2013_poster1

Boston University Department of Pharmacology & Experimental Therapeutics – Pfizer Symposium

Tuesday, November 5, 2013   8am to 7pm
Boston University Trustee Ballroom, 1 Silber Way, 9th Floor, Boston, MA

For more information, please contact Ms. Sara Johnson at pharm3@bu.edu or 617-638-4302.

September 2013 issue of The Pharmacologist now available

September 20th, 2013 in Recent News

TP September 2013.inddThe September 2013 issue of The Pharmacologist is now available online. Read about new Executive Officer Judith A. Siuciak, some thoughts from President Rick Neubig, the program for the Joint ASPET/Chinese Pharmacological Society Annual Meeting at Experimental Biology 2014, and more. Be sure to check it out!

 

 

 

In this issue: 

  • Introduction to new ASPET President, Judith A. Siuciak, Ph.D.
  • Message from new ASPET President, Richard R. Neubig, M.D., Ph.D.
  • ASPET Annual Meeting at Experimental Biology 2014: Program and Information
  • ASPET 2013 Annual Membership Survey Results
  • New ASPET Committee & Division Lists
  • The Case of Elizabeth Hughes: Juvenile Diabetes at the Dawn of Insulin, by Rebecca J. Anderson, Ph.D.
  • Career Center
  • Book Review, by Christine K. Carrico, Ph.D.
  • In the Spotlight: Interviews with ASPET Members
  • Obituaries: Toshio Narahashi and William L. Woolverton
  • Mid-Atlantic Pharmacology Society Annual Meeting program information
  • Great Lakes Chapter Annual Meeting abstracts

 

Originally published by the American Society for Pharmacology and Experimental Therapeutics

Wendy Wei Qiao Qiu, M.D., Ph.D., receives J&J CIAP Award

September 17th, 2013 in Recent News

10-3009-PHARMAHEAD-050Dr. Wendy Wei Qiao Qiu was chosen to receive the 2013 Johnson & Johnson Clinical Innovation Award Program (J&J CIAP) award. According to the BU Institute for Technology Entrepreneurship & Commercialization website, the J&J CIAP was designed to “stimulate innovative solutions to unmet clinical challenges emerging from the Boston University medical community” by funding research projects with the greatest potential to impact human health.

 

Dr. Qiu was chosen for this recognition from many talented Boston University practicing clinicians for her research on Alzheimer’s disease. As an awardee of the Clinical Innovation Award Program, she will be recognized at the program’s annual event, invited to serve as clinical advisor to the project team, and will have an opportunity to contribute to breakthrough medical technologies. In addition, she will be supported with an initial development grant of up to $15,000.

 

An Associate Professor of Psychiatry and Pharmacology,  Dr. Qiu is the Principal Investigator in the Laboratory of Molecular Psychiatry in Aging in the Department of Pharmacology & Experimental Therapeutics.

 

Congratulations, Dr. Qiu!